Olaparib Increases OS in Patients with Germline/Somatic BRCA+ Relapsed Ovarian Cancer
Patients with relapsed ovarian cancer who had germline or somatic BRCA mutations saw greater OS with olaparib, according to data from the LIGHT trial.
Related Articles
Trifluridine/Tipiracil Benefits Stage IV CRC With Molecular Residual Disease
Trifluridine/tipiracil improved DFS in stage IV CRC with molecular residual disease but not in the full ALTAIR study population.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Dr. David S. Hong presents the preliminary Phase 1 results on RMC-9805, a first-in-class, oral, RAS(ON) G12D-selective inhibitor, highlighting its promising safety, pharmacokinetics, and early…
Resilience of Adults With Cancer Comprises 4 Key Components – Oncology Nurse Advisor
An umbrella review of components of reliance among patients with cancer compared 20 instruments to find 3 that are ideal for these patients.
Dr Naumann on Next-Generation Antibody-Drug Conjugates in Ovarian Cancer
R. Wendel Naumann, MD, discusses next-generation antibody-drug conjugates in ovarian cancer.
Dr Lheureux on the Evolution of ADCs Since Mirvetuximab Soravtansine in Ovarian Cancer
Stéphanie Lheureux, MD, PhD, discusses the evolution of antibody-drug conjugates since mirvetuximab soravtansine in ovarian cancer.
Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Tracking Trump’s early impact on cancer policy Research and care disrupted, NCI programs face unpredictable future – The Cancer Letter
The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and…
With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda – The Cancer Letter
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States…
Validation of a Single Item Measure for Financial Toxicity Screening in Patients With Breast Cancer | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) has been linked to higher symptom burden and poorer clinical outcomes for patients with cancer. Despite the availability of validated tools to…
ASTROblog – American Society for Radiation Oncology (ASTRO)
The ASTROblog covers current topics in radiation oncology. Posts are authored by ASTRO members and staff. If you have a topic idea for a blog, email…
